Lucid Scientific
Series A in 2023
Lucid Scientific develops real-time cellular activity monitors for drug discovery and research. It serves academic institutions and pharmaceutical companies, offering innovative tools like RESIPHER for non-invasive, continuous measurement of oxygen consumption in cell cultures.
Micron Biomedical
Series A in 2022
Founded in 2014, Micron Biomedical is a clinical-stage biopharmaceutical company based in Atlanta, Georgia. It specializes in developing microneedle patches for vaccines, aiming to enhance protective effects and patient compliance while simplifying administration.
BioCircuit Technologies
Seed Round in 2022
BioCircuit Technologies, Inc. is a medical device company based in Atlanta, Georgia, founded in 2016. The company specializes in developing noninvasive electrophysiology devices that monitor, control, and repair peripheral nerves. By utilizing multi-electrode arrays and proprietary algorithms, BioCircuit's products enable clinicians to diagnose health conditions more effectively, track the progression of symptoms over time, and select tailored treatments for individual patients. This innovative approach enhances the ability of healthcare providers to address nerve-related health issues with greater precision and efficiency.
Codoxo, formerly known as Fraudscope, is a company dedicated to enhancing the affordability and effectiveness of the healthcare system. It has developed a Forensic AI Platform that employs a patented algorithm to swiftly identify issues and suspicious activities within healthcare plans, surpassing traditional detection methods. This technology facilitates smart investigation and fraud detection, allowing investigators and analysts to gain valuable insights and conduct comprehensive investigations of questionable claims. By utilizing advanced AI-based capabilities, Codoxo aims to ensure that healthcare resources are allocated to genuine patient care, ultimately contributing to a more efficient healthcare environment.
Antios Therapeutics
Series B in 2021
Antios Therapeutics, Inc. is a biopharmaceutical company based in Atlanta, Georgia, focused on developing innovative therapies for viral diseases. Founded in 2018 by Abel De La Rosa, Douglas Mayers, and Idean Marvasty, the company is dedicated to addressing the needs of patients infected with Hepatitis B and Hepatitis D viruses. Its lead product, ATI-2173, is an oral drug candidate aimed at providing a potentially curative treatment for Hepatitis B virus infections. With a leadership team that brings a wealth of experience, Antios Therapeutics is committed to advancing its therapeutic solutions in the field of viral diseases.
Lucid Scientific
Seed Round in 2020
Lucid Scientific develops real-time cellular activity monitors for drug discovery and research. It serves academic institutions and pharmaceutical companies, offering innovative tools like RESIPHER for non-invasive, continuous measurement of oxygen consumption in cell cultures.
Codoxo, formerly known as Fraudscope, is a company dedicated to enhancing the affordability and effectiveness of the healthcare system. It has developed a Forensic AI Platform that employs a patented algorithm to swiftly identify issues and suspicious activities within healthcare plans, surpassing traditional detection methods. This technology facilitates smart investigation and fraud detection, allowing investigators and analysts to gain valuable insights and conduct comprehensive investigations of questionable claims. By utilizing advanced AI-based capabilities, Codoxo aims to ensure that healthcare resources are allocated to genuine patient care, ultimately contributing to a more efficient healthcare environment.
Apptega
Seed Round in 2020
Apptega Inc. is a cybersecurity management software company based in Atlanta, Georgia, founded in 2018. The company develops a platform that enables organizations to build, manage, and report on their cybersecurity functions through a suite of specialized applications. This platform connects with established frameworks and facilitates automatic data sharing with other applications, streamlining the management of cybersecurity programs. Apptega's solutions are designed to assist organizations of all sizes, particularly chief information officers and Fortune 1000 companies, in organizing their cybersecurity efforts effectively. By simplifying administrative tasks and providing a centralized online dashboard, Apptega helps clients enhance their cybersecurity posture and navigate the complexities of compliance and modern threats.
Acivilate
Seed Round in 2017
Acivilate develops Pokket, a cloud-based software platform that connects justice agencies and human service providers to support returning citizens. The platform coordinates public and private social services case management, enabling secure data exchange among parole and probation agencies, courts, treatment programs, and community providers to organize rehabilitation efforts and reduce recidivism. Founded in 2014 and based in Atlanta, Acivilate emphasizes outcomes measurement and streamlined collaboration to address challenges faced by individuals reentering the community.
Carbice
Seed Round in 2017
Carbice Corporation, founded in 2012 and based in Atlanta, Georgia, specializes in thermal interface technology components. The company is renowned for its innovative product, Carbice Carbon, which effectively lowers device temperatures and facilitates heat dissipation from product packaging. This technology is designed to meet the performance, reliability, and assembly cost challenges faced in critical sectors such as electronics, energy, and industrial applications. Carbice's thermal interface materials are composed of a composite of recycled aluminum and aligned carbon nanotubes, addressing the growing need for efficient thermal management in electronic devices. In addition to its headquarters in Atlanta, Carbice has an office in London and plans to establish a presence in Toulouse, France, reflecting its commitment to global outreach and innovation in thermal applications.
Codoxo, formerly known as Fraudscope, is a company dedicated to enhancing the affordability and effectiveness of the healthcare system. It has developed a Forensic AI Platform that employs a patented algorithm to swiftly identify issues and suspicious activities within healthcare plans, surpassing traditional detection methods. This technology facilitates smart investigation and fraud detection, allowing investigators and analysts to gain valuable insights and conduct comprehensive investigations of questionable claims. By utilizing advanced AI-based capabilities, Codoxo aims to ensure that healthcare resources are allocated to genuine patient care, ultimately contributing to a more efficient healthcare environment.
Axion BioSystems
Venture Round in 2016
Axion BioSystems, Inc. is a life science instrumentation company based in Atlanta, Georgia, specializing in multi-electrode array technology. Founded in 2007, the company provides solutions for cellular information analysis, catering to research, clinical, and drug discovery markets. Its product lineup includes single-well systems, stimulating and recording channels, multi-well systems, and integrated circuits designed to eliminate stimulation artifacts. Additionally, Axion BioSystems offers microelectrode array plates and the Axion BioSystems Integrated Studio (AxIS), as well as a product known as Lumos. Through its innovative technology, the company aims to enhance the understanding of cellular behavior and facilitate advancements in biomedical research.
StarMobile
Seed Round in 2015
StarMobile, Inc. is an Atlanta-based company that specializes in cloud-based enterprise mobility solutions. Founded in 2012, it provides a codeless platform that enables organizations to transform existing enterprise applications—whether on-premise or cloud-based—into mobile applications without the need for coding or extensive technical skills. Utilizing a unique remote computing protocol called MORPH, StarMobile dynamically renders applications for any mobile device, maintaining a native user experience and seamless device integration. The platform is designed for simplicity, requiring minimal configuration and maintenance while offering scalability and robust security features. With a leadership team boasting over 125 years of combined experience in enterprise software and mobile computing, StarMobile is positioned to deliver innovative mobility solutions that enhance operational efficiency for businesses.
Lumense, Inc., founded in 2011 and based in Atlanta, Georgia, specializes in developing real-time, in situ chemical and biological sensors. The company's technology, originally derived from research at Georgia Tech, utilizes optical interferometric sensor technology to detect a wide range of substances, including chemicals, cellular organisms, viruses, proteins, and toxins. Lumense has exclusively licensed this core intellectual property and continues to enhance it. The company offers standard products in specific focus areas and collaborates with leading industries to develop custom sensors tailored to their needs.
Celtaxsys
Series D in 2015
Celtaxsys, Inc. is a clinical-stage biopharmaceutical company based in Atlanta, Georgia, founded in 2007. The company specializes in the discovery and development of novel therapeutics aimed at treating inflammatory diseases, including cystic fibrosis and moderately severe acne. Its lead product, CTX-4430, is a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells. Celtaxsys also focuses on manipulating immune cell migration and activation to develop treatments for cancer, inflammatory conditions, and autoimmune diseases. Through its innovative approach, the company aims to provide effective therapies for patients suffering from rare and serious inflammatory disorders.
StarMobile
Seed Round in 2015
StarMobile, Inc. is an Atlanta-based company that specializes in cloud-based enterprise mobility solutions. Founded in 2012, it provides a codeless platform that enables organizations to transform existing enterprise applications—whether on-premise or cloud-based—into mobile applications without the need for coding or extensive technical skills. Utilizing a unique remote computing protocol called MORPH, StarMobile dynamically renders applications for any mobile device, maintaining a native user experience and seamless device integration. The platform is designed for simplicity, requiring minimal configuration and maintenance while offering scalability and robust security features. With a leadership team boasting over 125 years of combined experience in enterprise software and mobile computing, StarMobile is positioned to deliver innovative mobility solutions that enhance operational efficiency for businesses.
Soneter
Venture Round in 2014
Soneter, LLC is a manufacturer of advanced water flow and leak sensors designed for the multifamily housing industry. Established in 2010 and headquartered in Atlanta, Georgia, the company specializes in providing real-time monitoring and alerts to protect against water damage caused by undetected leaks. Soneter's products are targeted towards building owners and tenants, offering solutions that enable detailed consumption analysis and hazard predictions through ultrasonic sensors and processing techniques. As a subsidiary of Reliance Worldwide Corporation Limited since November 2016, Soneter continues to contribute to water leak detection and sub-metering services in various markets, enhancing the management of water resources for its customers.
Lumense, Inc., founded in 2011 and based in Atlanta, Georgia, specializes in developing real-time, in situ chemical and biological sensors. The company's technology, originally derived from research at Georgia Tech, utilizes optical interferometric sensor technology to detect a wide range of substances, including chemicals, cellular organisms, viruses, proteins, and toxins. Lumense has exclusively licensed this core intellectual property and continues to enhance it. The company offers standard products in specific focus areas and collaborates with leading industries to develop custom sensors tailored to their needs.
StarMobile
Seed Round in 2013
StarMobile, Inc. is an Atlanta-based company that specializes in cloud-based enterprise mobility solutions. Founded in 2012, it provides a codeless platform that enables organizations to transform existing enterprise applications—whether on-premise or cloud-based—into mobile applications without the need for coding or extensive technical skills. Utilizing a unique remote computing protocol called MORPH, StarMobile dynamically renders applications for any mobile device, maintaining a native user experience and seamless device integration. The platform is designed for simplicity, requiring minimal configuration and maintenance while offering scalability and robust security features. With a leadership team boasting over 125 years of combined experience in enterprise software and mobile computing, StarMobile is positioned to deliver innovative mobility solutions that enhance operational efficiency for businesses.
Clearside Biomedical
Series A in 2013
Clearside Biomedical is a biopharmaceutical company focused on developing treatments for serious eye diseases. It specializes in delivering drugs directly to specific compartments of the eye using its proprietary suprachoroidal injection platform, aiming to restore and preserve vision.
Urjanet, Inc. is a company that specializes in providing a cloud-based platform for automated access to utility data. Founded in 2009 and headquartered in Atlanta, Georgia, with an additional location in Chennai, India, Urjanet connects directly to utility providers to acquire and normalize utility bills and interval data. Its offerings include automated access to utility bill data across various utilities, granular measurements of energy consumption, and advanced metering infrastructure data without requiring additional hardware or software. The platform also features capabilities for weather data analysis and alerts for billing and consumption anomalies. Urjanet's solutions are designed to improve business intelligence, energy management, accounting, and procurement processes for organizations, enabling them to enhance financial performance, energy efficiency, and sustainability.
Pindrop
Seed Round in 2012
Pindrop specializes in voice-driven security and intelligence solutions for enterprises. It leverages unique audio analysis technology to authenticate calls, detect fraud, and enhance customer experiences across various industries.
Clearside Biomedical
Series A in 2012
Clearside Biomedical is a biopharmaceutical company focused on developing treatments for serious eye diseases. It specializes in delivering drugs directly to specific compartments of the eye using its proprietary suprachoroidal injection platform, aiming to restore and preserve vision.
Urjanet, Inc. is a company that specializes in providing a cloud-based platform for automated access to utility data. Founded in 2009 and headquartered in Atlanta, Georgia, with an additional location in Chennai, India, Urjanet connects directly to utility providers to acquire and normalize utility bills and interval data. Its offerings include automated access to utility bill data across various utilities, granular measurements of energy consumption, and advanced metering infrastructure data without requiring additional hardware or software. The platform also features capabilities for weather data analysis and alerts for billing and consumption anomalies. Urjanet's solutions are designed to improve business intelligence, energy management, accounting, and procurement processes for organizations, enabling them to enhance financial performance, energy efficiency, and sustainability.
Damballa is a company specializing in advanced threat protection, focusing on the identification and mitigation of active security threats that bypass traditional prevention methods. Utilizing patent-pending solutions that integrate data science and machine learning, Damballa automatically detects infections and highlights devices posing the highest risk to enterprises. Its technology is designed to discover threats without prior knowledge of them and is applicable across various device types and operating systems. The company protects nearly a billion endpoints worldwide, serving clients in every major market, including large internet service providers and telecommunications companies. Damballa's software also addresses issues related to botnet formation, helping organizations combat the unauthorized transmission of spam and viruses over the Internet.
Damballa is a company specializing in advanced threat protection, focusing on the identification and mitigation of active security threats that bypass traditional prevention methods. Utilizing patent-pending solutions that integrate data science and machine learning, Damballa automatically detects infections and highlights devices posing the highest risk to enterprises. Its technology is designed to discover threats without prior knowledge of them and is applicable across various device types and operating systems. The company protects nearly a billion endpoints worldwide, serving clients in every major market, including large internet service providers and telecommunications companies. Damballa's software also addresses issues related to botnet formation, helping organizations combat the unauthorized transmission of spam and viruses over the Internet.